Panel OKs Merck's Vioxx Return to Market (Reuters)


Reuters - Merck & Co. Inc.'s
withdrawn arthritis drug Vioxx is safe enough to rejoin
Pfizer's rival pain relievers Celebrex and Bextra on the U.S.
market, an advisory panel said after concluding that all three
medicines posed some level of heart risk.

Read more...